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Sara Bennett1*, Gina Lagomarsino2, Jeffrey Knezovich3 and Henry Lucas3Abstract
Background: Given the rapid evolution of health markets, learning is key to promoting the identification and uptake of
health market policies and practices that better serve the needs of the poor. However there are significant challenges to
learning about health markets. We discuss the different forms that learning takes, from the development of codified
scientific knowledge, through to experience-based learning, all in relationship to health markets.
Discussion: Notable challenges to learning in health markets include the difficulty of acquiring data from private health
care providers, designing evaluations that capture the complex dynamics present within health markets and developing
communities of practice that encompass the diverse actors present within health markets, and building trust and mutual
understanding across these groups.
The paper proposes experimentation with country-specific market data platforms that can integrate relevant evidence
from different data sources, and simultaneously exploring strategies to secure better information on private providers
and health markets. Possible approaches to adapting evaluation designs so that they are better able to take account
of different and changing contexts as well as producing real time findings are discussed. Finally capturing informal
knowledge about health markets is key. Communities of practice that bridge different health market actors can help
to share such experience-based knowledge and in so doing, may help to formalize it. More geographically-focused
communities of practice are needed, and such communities may be supported by innovation brokers and/or be built
around member-based organizations.
Summary: Strategic investments in and support to learning about health markets can address some of the challenges
experienced to-date, and accelerate learning that supports health markets that serve the poor.
Keywords: Health care market, Learning, Developing countriesBackground
A health market consists of the set of interactions that
occur between multiple health actors – such as health
care providers, payors, regulators and service users –
and the rules and regulations that govern their actions
and interactions. Providers, payors and regulators may
be either public or private entities operating either on a
for-profit or on a not-for-profit basis. Health markets in
low and middle income countries (LMICs) are currently
experiencing extremely rapid change due to technological
and organizational innovation, as well as political trans-
formation [1]. For example, social franchising schemes that
provide specific health services such as family planning ser-
vices or TB care are expanding rapidly in countries [2,3],
and sometimes even crossing national borders. As govern-
ments roll out social health insurance schemes, private for-* Correspondence: sbennett@jhu.edu
1Johns Hopkins School of Public Health, Baltimore, MD, USA
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reproduction in any medium, provided the orprofit providers may be attracted into new health care mar-
kets by the increased ability of the population to afford
health care [4]. The revolution in information and commu-
nications technology has provided opportunities to create
networks across health care providers, sometimes linking
informal health care providers with private telemedicine
centers [5]. For many years the predominant focus of health
systems research has been the public health care sector, ac-
cordingly evidence concerning what happens in the private
sector is relatively weak. Now, change in health markets is
occurring so rapidly that typically there is insufficient time
(not to mention funding) to formally evaluate the effective-
ness of new interventions.
This paper focuses on strategies for strengthening
learning about health markets in the future. While from
a business perspective a focus on the bottom line may
be sufficient, from a public health perspective, more in-
formation is needed about how changes in the market
affect people’s access to quality health services. Suchl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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promote good practices, and particularly those that im-
prove access to care for the poor. There have been sev-
eral recent efforts to promote the development of
learning communities around health marketsa, however
this paper argues that many gaps remain, and that fur-
ther effort and resources need to be invested in learning
about health markets.
Learning is a broad term, and we use it here advisedly.
Learning can encompass the acquisition of knowledge or
skills through experience, practice, study or taught
courses and may take the form of individual learning,
organizational learning or even learning across systems
[6-10]. In recent years the health sector has seen a surge
of interest in promoting the application of formal re-
search evidence to decision making [11,12], but manage-
ment specialists have focused more on the contribution
of implicit and tacit evidence to learning and decision
making [13]. Figure 1 unpacks the multiple forms of evi-
dence and learning that are needed to promote strong
and efficient health markets, from formal studies that
seek to evaluate the effects of interventions, through
more descriptive, empirical information that describes
what is going on in health markets and hence why cer-
tain actions or interventions might be required, to more
implicit or experience-based forms of learning.
Given the dearth of previous literature concerning
learning about health markets, we have purposefully
maintained a broad focus in our paper. We aim to pro-
vide an overview of the landscape of health market
learning, thus providing a foundation and stimulation
for others to dig deeper into particular aspects. The
paper proceeds by describing barriers to more effective
learning about health markets and then identifies andFigure 1 Different forms of knowledge and their relevance to healthelaborates two separate, but related strategies to address
learning challenges. The first focuses on approaches to
generating evidence and knowledge about health mar-
kets. The second considers mechanisms for supporting
learning across different types of actors in health mar-
kets. Finally we conclude with practical recommenda-
tions about how to move the agenda forward.
Main text
Barriers to learning in health markets
We consider challenges to (i) knowledge building, which
concerns how knowledge regarding health markets is
generated, and is particularly focused on more formal
knowledge (e.g. evaluations, research) and (ii) knowledge
sharing and evidence use, which concerns the interac-
tions between different actors and the application of
knowledge to decisions, and is focused more on the ex-
change of implicit and best practice knowledge.
Challenges to knowledge building
It can be very challenging to acquire data from private,
particularly for-profit, health care providers. Few such
providers are included in government reporting systems,
and their information is often incomplete and unreliable
[14]. Even private providers operating fully within gov-
ernment regulations are often reluctant to share sensi-
tive data (financial performance, services provided, etc.)
because of concerns that it may, inter alia, be disclosed
to competitors, or to officials able to inhibit activities or
seek bribes. Moreover, in many countries the poor ob-
tain care mainly from unlicensed or moonlighting public
sector providers [15]. Both groups are unlikely to pro-
vide information that might be passed to government
agencies.markets.
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tained from household surveys, those data are typically
limited in scope and often unreliable [16]. Respondents
cannot assess technical quality of care, and often cannot
reliably report services provided, fees paid, provider
qualifications or even if providers were public or private.
Exit or mystery patient surveys [17,18] can provide add-
itional insights, but demand-side surveys alone cannot
deliver detailed understanding of the diverse range of
private providers.
Even with access to reliable information, evaluating
health market initiatives is challenging. They typically in-
volve many interconnected parts and players within a
larger system and have potential consequences well be-
yond the intended health outcomes: the science of de-
signing such evaluations is poorly understood and rarely
practiced [19]. For example, Shah et al. [20] present a
rigorous and systematic approach to evaluating family
planning franchises, but their framework does not ad-
dress the wider implications of such interventions, in-
cluding how franchised services affect the quality or
price of similar services on offer from non-franchised
providers. While other conceptual models allow consid-
eration of the broader ramifications of market interven-
tions [21], these have rarely been translated into solid
empirical studiesb.
Another key challenge concerns contextual factors: the
internal management context of an organization (includ-
ing leadership, financial systems etc.); the health market
context (including market concentration, regulatory en-
vironment, access to capital), and the broader socio-
economic context (including GNP per capita, extent of
formal sector employment) may all influence the effect-
iveness of a market intervention. Many evaluations take
inadequate account of such factors and thus it is difficult
to assess the transferability of findings to other contexts.
Further, impact evaluations typically take years to im-
plement, and technologies and business models often
evolve more quickly than the evidence base. Many evalu-
ations are of pilot exercises and often ignore the fact that
the challenges of implementing the same intervention at
scale may be different in nature and considerably more
complex. Moreover, pilots may be feasible for evaluation
of new business models but are often of limited value in
understanding initiatives designed to influence the mar-
ket – such as regulatory, tax and incentive policies –
which are, arguably, the interventions where knowledge
needs are greatest.
Similarly, evaluations typically have time horizons of
one to three years and do not explore how interventions
may give rise to unexpected side-effects over the longer
run as stakeholders adjust to a new environment, shift
the long term balance of market power, or shape market
institutions in ways that may have long lasting effects.Given the significance of path dependence in health sys-
tems [22], these issues cannot be ignored. In particular,
any specific health market constellation will create inter-
est groups likely to develop entrenched positions and
political power over time, and fight later attempts at re-
form or regulation [23].
A final set of issues concerns the institutional arrange-
ments for documenting market experiences: frequently
no provision is made to fund for independent evaluation,
and the implementers of initiatives are made responsible
for evaluating their own performance and documenting
effects. This raises serious concerns about bias and the
trustworthiness of data.
Challenges to knowledge sharing and evidence use
Health markets in LMICs are dominated by multiple,
small-scale, poorly coordinated actors. In a complex system
such as a health market, no single actor will have a
complete view of the change processes occurring; so, there
is a need to bring together different types of actors, includ-
ing government, private providers, regulators, payors and
market analysts, to develop shared learning. However there
is a widespread belief that mutual distrust and skepticism
about motivations are prevalent between public and private
sector actors [24]. Without overcoming this mutual dis-
trust, joint learning is unlikely to be successful.
Relatedly, different actors in health markets may hold
very different paradigms about the nature of the know-
ledge and evidence required for decision-making: for ex-
ample, private sector firms may place greater value on
evidence of the impact they have on their customers or
patients, rather than population-level outcomes. They
may also look to financial indicators or market share as
an indicator of success, whereas public health experts
may seek impact evaluations based on established health
indicators.
Finally practical questions persist about how best to
develop organizational and institutional structures that pro-
mote the exchange and use of evidence regarding health
markets. Recently, international actors have invested in the
development of communities of practice that aim to share
information across countries and across different types of
actors, but these often face serious challenges in terms of
language barriers, time pressures on participants, and main-
taining up-to-date information. While new technologies
might help mitigate some of these challenges to learning,
there needs to be clearer and more systematic thinking
about quite how to address such practical issues.
Addressing challenges to knowledge building
Answering descriptive questions better
Country governments often lack the most basic descrip-
tive data concerning health markets outside of the public
sector: where are private providers located and what
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extent that data do exist they typically only cover formal
private sector providers (see Table 1).
The Health Metrics Network framework for health
information architecture in low- and middle-income
countries [25] emphasizes the need for routine data col-
lection from private health care providers. However,
private for-profit providers are rarely incorporated in na-
tional information systems, and there has been little ser-
ious discussion of the feasibility of integrating private
sector reporting. Strategies to improve market data in-
clude incentives for private providers to register with or
provide health services data to government, or stronger
consequences for failing to do so, or ensuring that a
sample of private practitioners is included within routine
health facility surveys. While global actors have dis-
cussed such strategies, to-date there has been little effort
to support their implementation. An alternative ap-
proach that might be of interest, is that taken by theTable 1 Sources of data on private health care providers
Data source Nature of data
Household surveys
(eg. Demographic
and Health Surveys)
Provides household level data on utilization o
providers
Private providers registered
with MOH
Regulatory databases
Facility surveys (eg. Service
Provision Assessment of DHS)
Survey of health facilities covering aspects su
availability of services, staffing and resources,
services provided
Demographic surveillance
sites (eg. Matlab, Bangladesh;
Kintampo, Ghana)
Frequent, regular collection of household hea
from surveillance sites, including care seeking
Data collected by payors
such as insurance schemes
Typically encompasses data on patient charac
diagnosis, services provided, and price of care
Financial flows
(eg. PETS, NHA)
PETS track the flow of government finance th
health care system. NHA includes componen
at private sector financing and expenditure in
sector
Routine Health Management
Information systems
Routine data typically including health service
Financial data Data on company revenues, capital, profitabil
Companies and formal private providers typic
to government for tax reasonsCenter for Studying Health Systems Change [26]. The
Center has conducted a series of longitudinal studies of
health markets in 12 communities across the United
States. Center research staff visit the communities every
two-three years and employ primarily interviews with a
range of different market stakeholders to describe and
analyze changes in financing, organization and delivery of
health care within these geographically defined markets.
In high-income countries that have large private sec-
tors, public or private payors typically collect routine
health information from both public and private health
care providers. Because payment is contingent on
reporting, provider incentives are aligned. The growing
commitment to universal health coverage, often linked
to the development of health insurance and social pro-
tection schemes in lower-income countries, provides a
potential window of opportunity to strengthen market-
oriented health management information systems to de-
liver the kind of data needed for public health policy.Issues
f private Reliance on consumer recall for data on price, quality of
services is problematic.
Informal providers typically not included.
Only basic data on formal providers collected.
While many LMICs have regulatory frameworks for HMIS,
enforcement is often partial leading to incomplete or
out-of-date information.
ch
and actual
Can include private providers but does not do so
routinely.
No regular roster of facility surveys established despite
previous discussions among global actors about the
importance of such information.
lth data
behavior
INDEPTH (the society of LMIC surveillance sites) is still
working on developing better linkages between such data
and facility surveys.
While some surveillance data have explored private sector
utilization, there remains considerable scope to expand
further.
teristics,
received
Partial coverage of health insurance schemes in low and
middle income countries means that currently such
databases typically cover only a small proportion of the
population. Further data collected is designed to meet the
needs of payors, rather than informing broader policy
decisions.
rough the
ts that look
the private
NHA is relatively well developed with respect to the
private sector. PETS typically only cover private sector
actors, when public funds flow to them.
s data Private providers typically not included, with the exception
of notifiable diseases. Extent of enforcement of regulations
on notifiable diseases is unclear.
ity.
ally report
Infrequently used in research or linked with other data
sources.
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Recent years have seen a spate of systematic reviews re-
lated to health markets, a number of which are summa-
rized in Table 2. In most cases review authors found a
good number of studies that could be included in the
review, however the quality of the primary studies
included was heavily criticized. Most of the reviews
address relatively self-contained interventions in the
market that have been planned and implemented by the
government or an NGO, such as contracting out of ser-
vices by government, social franchising or social market-
ing initiatives. Strictly for-profit private sector initiatives
appear less likely to be evaluated, partly because of the type
of evidence that is valued in the commercial sector, but also
because traditional evaluation approaches are ill-suited to
private sector initiatives that are continuously evolving as
entrepreneurs adapt strategies to changing market condi-
tions. Further, relatively few of the reviews focus on market
governance mechanisms (such as regulation).Table 2 Key findings regarding the nature of evidence from r
Authors Title # studies
Patouillard
et al. [27]
Can working with the private for-profit sector
improve utilization of quality health services by
the poor? A systematic review of the literature
52
Berendes
et al. [28]
Quality of private and public ambulatory health
care in low and middle income countries:
Systematic review of comparative studies
80
Montagu
et al. [29]
Private versus public strategies for health service
provision for improving health outcomes in
resource-limited settings
21
Kiwanuka
et al. [30]
Dual practice regulatory mechanisms in the health
sector: A systematic review of approaches and
implementation
31
Liu
et al. [31]
The effectiveness of contracting-out primary health
care services in developing countries: A review of
the evidence
16
Koehlmoos
et al. [32]
Social franchising evaluations: A scoping review 3 systema
primary st
Evans
et al. [33]
Systematic review of public health branding 3 experim
5 quasi-ex
25 observa
Source: extracted from 3ie database of systematic reviewsWith regard to evaluations of interventions in health
markets, there is both a need to strengthen traditional
impact evaluations and also to experiment with alterna-
tive types of evaluation. Traditional impact evaluations
face numerous challenges, such as being commissioned
too late or with insufficient funding [34]. Initiatives such
as 3ie are beginning to tackle this, but there remain
missed opportunities for learning as new private sector
initiatives are often not identified in advance, and are
started without concomitant investments in evaluation.
Further research is also needed in order to understand
how context affects market interventions. Strengthened
efforts to map contextual factors would help in terms of
assessing the transferability of findings. The notion of
developing a limited number of market archetypes de-
serves further exploration: for example, some health
markets are heavily dominated by social health insurance
schemes, others rely on public provision combined with
out-of-pocket payment for health care, still others focusecent systematic reviews
included Conclusions regarding nature of evidence available
The authors highlight that only a handful of studies
assess the impact of private-sector involvement on usage
and quality of health care for the poor. While many stud-
ies show increased access to health services for the poor,
due to the quality of existing studies it is not possible to
prove that private-sector involvement in health care is
beneficial to the poor. The authors also recommend a
focus on robust evaluation designs in future research,
because current data are insufficient and of poor quality.
The authors stress the need for more research using
standardised outcome measures, and assessing strategies
and interventions, to improve private ambulatory
health-care services.
Overall the quality of the evidence was rated as either
low or very low and the authors conclude there is a
need for further evidence comparing health outcomes of
public-sector versus private-sector health care.
Majority of studies identified were policy analyses,
country case studies, cross-sectional surveys, or economic
models. No impact evaluations were identified, and no
studies assessed the impact of regulatory mechanisms on
dual practice.
The authors highlight the need for more research on the
possible unanticipated consequences of contracting-out
interventions. To-date very few evaluations have ad-
dressed these.
tic reviews, 9
udies
The authors conclude that there is a lack of rigorous
evaluations of the effectiveness of social franchising, and
that future research should address issues related to
implementation, such as adherence and sustainability.
ental studies
perimental
tional
The authors conclude that there are problems in the
existing literature with reference to the standardization of
reporting, terminology and measurement. They express
the need for more rigorous research designs such as
randomised controlled trials and longitudinal designs to
determine the effectiveness of public health branding
interventions on health behaviour.
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possible to develop a set of market archetypes, then pol-
icy and decision-makers would be able to situate their
own health market among these archetypes and accord-
ingly better understand the implications of research
findings from elsewhere for their particular setting. This
idea has been suggested before in the context of health
systems [35], but has not been properly explored in the
context of health markets.
Interventions in markets frequently encounter unex-
pected effects beyond their immediate targets [21].
Evaluation designs need to do a better job at measuring
anticipated effects, but also searching for unanticipated
ones, for example: have regulatory interventions shifted
care seeking to the unregulated private sector? Have suc-
cessful franchising networks, through competitive pres-
sures, managed to increase the quality and lower the
price of providers outside of the franchise? We need cre-
ative ways to capture rapid evolution in the nature of
interventions, and the forces that have shaped this evo-
lution, such as actor power, information exchange and
market competition. Unfortunately there is little prior
research concerning the spread of innovations in com-
plex systems that can inform such studies [36].
Given the dynamic and adaptive nature of health
markets (described above), evaluations need to track
interventions over multiple time points rather than
employing simple before and after studies. Demographic
surveillance sites, with their frequent rounds of house-
hold data collection offer particular promise in this re-
spect, especially if they could be linked with facility
surveys. Establishing nationally representative, routine
facility surveys that incorporate private providers would
also enhance our ability to understand and evaluate the
effects of health market interventions at scale. Further,
given the dynamism of many health markets, there are
frequently multiple different market-related interven-
tions that may be occurring in overlapping areas of the
country. Conducting controlled studies in such environ-
ments may be close to impossible, and as others have
argued there is a need to examine how a national
information platform could support evaluations in such
contexts [37].
Answering applied policy and practice questions better
Even with the findings of robust evaluations in hand, it
is frequently difficult to address the kind of questions
that policy-makers and practitioners are interested in,
that often concern implementation processes, for ex-
ample: how should we go about implementing a new
regulatory regime? What challenges are we likely to face
in contracting out specialist services? How do we set up
quality assurance mechanisms in a franchise agreement?
Answers to such questions need to draw upon the bestresearch evidence available, both in terms of what has
worked and why, and also the implicit, informal know-
ledge possessed by practitioners who have struggled with
similar questions in their own contexts.
A major question concerns how to systematically col-
late implicit and informal knowledge. Much useful infor-
mation on health markets is currently generated through
market research and other non-academic, unpublished
industrial analysis on a proprietary basisc. In commercial
marketplaces, business consultants may be repositories
of such information, having worked across multiple or-
ganizations, and assessed the effects of different business
practices. Although staff of multilateral and bilateral de-
velopment agencies and their contractors may possess
some of this tacit knowledge, they are typically not in a
position to acquire the kind of skills and expertise of
market researchers, dedicated to a particular geograph-
ical market. Collaborations with market researchers may
help to consolidate informal information about health
markets.
While analysts often discuss separately the kind of
processes required for formal research versus “learning
by doing” (see Figure 1) [38], in practice these two differ-
ent approaches to learning can complement each other
and the interaction between formal and informal know-
ledge can drive the crystallization of implicit ideas in a
process sometimes referred to as the SECI model [13]d.
Historically the health sector has not been particularly
good at facilitating communication between those fo-
cused on formal scientific evidence and those possessing
tacit knowledge, but for the reasons described above,
this seems to be a particularly important interface for
health markets, and one that is discussed in more detail
below in the section on facilitating learning.
Addressing challenges to knowledge sharing
Communities of practice
Where solid, scientific knowledge about health markets
exists it is perhaps best conveyed through structured, di-
dactic training courses. Such courses are currently avail-
able as part of graduate training programs at universities
across the world, and through short course training,
such as that conducted by the World Bank Institute.
However, where knowledge is evolving rapidly, and pri-
marily exists in the form of tacit knowledge, training
courses are unlikely to be very effective and establishing
strong communities of practice (“know who”) may be
more useful than transferring codified, explicit know-
ledge (“know what”). Creating connections between dif-
ferent actors interested in health markets may be key to
stimulating innovation and the diffusion of promising
new interventions. Developing communities of practice
is particularly important for health markets where there
is frequently distrust and a lack of communication
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ide in multiple different organizations (such as funding
agencies, regulators, provider organizations). Lack of
trust not only inhibits the development of communities
of practice but can also interfere with learning as actors
may be reluctant to test ideas or voice thoughts that are
not yet fully developed [39].
Accordingly effective learning processes for health
markets need to (i) combine formal, explicit knowledge
with informal tacit knowledge and (ii) build communi-
ties of practice [4] that break down barriers that separate
different types of health market actors.
New approaches to organizing learning events are
emerging and these need to be encouraged and evalu-
ated. For example, instead of short workshops or meet-
ings, learning events may occur over a period of months,
with online exchange building to a focal, face-to-face
event, and then subsequent follow-up online, or perhaps
an extended series of engagements in which the same
group of actors meet on a regular basis [40]. Such an ap-
proach allows time for relationships to be built and for
trust to develop. Collaborative learning, an approach
already widely employed in formal educational settings,
is increasingly being applied outside of formal educa-
tional settings to dispersed networks of people. For
example a group of implementers operating in different
locations but working on similar issues and a similar
timeline may communicate regularly, perhaps with
the support of an experienced facilitator and jointly
problem-solve.
Many of the existing learning initiatives for health
markets are global in nature and broadly encompass
multiple market-based health models (e.g. the Center for
Health Market Innovations, and the Private Sector in
Health Thematic Working Group), however as commu-
nities tend to work better where there is extended ex-
change and significant trust between participants, it may
be worthwhile to develop more geographically and/or
thematically focused communities of practice, so as to
enable more frequent and sustained interactions and
hopefully faster and more effective learning cycles.
Institutional mechanisms to support learning
In some sectors there has been a strong history of self-
organization for learning. For example, the micro-credit
field has been very effective at building institutions to
support communities of practice through organizations
such as CGAP, The Microfinance Information Exchange
and Imp-Act. To-date the institutions to support com-
munities of practice around health markets have largely
been dominated by global (northern) actors, and have
centered on “experts” rather than practitioners. However
communities of practice are most likely successful when
they remain focused on practitioner experiences andneeds [4] and thus require leadership from within the
community, albeit from expert community members.
An alternative approach is that of an innovation bro-
ker that has been defined as “an organization acting as a
member of a network of actors […] that is focused
neither on the organization nor the implementation of
innovations, but on enabling other organizations to
innovate” [41]. Such brokers can help identify needs,
mutual interests and connect different actors to each
other. In the context of health markets, an innovation
broker could help to identify learning needs and mutual
interests across different market actors, and coordinate
learning events. Local organizations, with extensive ex-
perience in health markets would be best placed to play
this role. Access Health in India and the Philippine Insti-
tute for Development Studies, with support from CHMI,
are beginning to take up this challenge – giving awards
for outstanding innovators in health markets, and foster-
ing linkages between innovators, policymakers, and fun-
ders. It is critical that social objectives are strongly
reflected in their mission, and that part of their mandate
is to set up learning systems so that positive adaptations
get pursued, rather than simply those that serve the
powerful.
A further alternative organizational form for the con-
solidation and dissemination of tacit knowledge may be
through hybrid organizations that combine detailed mar-
ket knowledge with a mission to support good practice.
The US-based Advisory Board Company (a membership
based private company, with a strong social mandate to
improve hospital performance) could be an interesting
model to explore in this respect. Such approaches may
hold the promise of developing more timely evidence
that is better geared to the needs of implementers than
much traditional academic research.
Conclusions
Enhancing learning about the characteristics of health
markets, and how interventions such as social franchis-
ing or regulation affect their operations, is key to better
decision-making. Policy-makers, social entrepreneurs
and the corporate sector all need better evidence regard-
ing health markets. This paper has identified three broad
areas where targeted investments could move the health
market learning agenda forward.
First, a concerted initiative is needed to strengthen
data platforms for health markets. Currently data regard-
ing health markets is fragmented and rarely brought
together in a comprehensive fashion. Using specific
countries as pilots, existing information sources could
be reviewed, relevant variables identified and collated in
a health market data platform. Such a data platform
could combine information from routine information
systems, household surveys, facility surveys, expenditure
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health surveillance sites. Concurrent with this collation
of existing information sources, new initiatives should be
piloted that strive to strengthen market data availability:
for example initiatives could seek to improve private
provider participation in health information systems, or
experiment with new ways to capture data on specific
geographic health markets within a country.
Policies promoting universal health coverage consti-
tute a significant opportunity to build understanding of
health markets. There is a need to ensure that appropri-
ate data collection systems are embedded within payor
management information systems (for example the data
collected through routine claims, accreditation, provider
empanelment processes etc.) as such systems are estab-
lished in low and middle income countries.
Second, new approaches and increased investment in
rigorous evaluations of health market interventions are
critical. Evaluations need to better reflect and have
sharper tools for analyzing market contexts, including
the broader market impact of specific interventions.
They also need to be able to capture the evolution of
market interventions over time, and enable more real-
time learning from such interventions. While evaluation
designs for specific business models (such as social
franchising arrangements) are relatively well established,
appropriate approaches to evaluating policies or regula-
tions intended to shape the market environment and
change organizational incentives require further devel-
opment. According to good evaluation practice, evalua-
tors should be somewhat separate from implementers,
but there is also a need for strong communication be-
tween the two so that evaluation designs are responsive
to the ongoing evidence needs of implementers, and so
opportunities for important empirical research can be
identified in advance to enable sound methodology. If
greater investment in evaluation is to be made, then it
may make sense to identify evaluation priorities and tar-
get investments to address specific questions.
Finally, communities of practice hold much promise in
terms of helping practitioners to address challenges in
policy implementation or business innovation. More
geographically and thematically focused communities of
practice are needed, especially ones that encompass di-
verse stakeholders. Regional “innovation brokers” may
be able to facilitate and support the development of such
communities of practice. Given how nascent our under-
standing of communities of practice is, it will be import-
ant to evaluate what works and what does not work with
respect to such communities.
While this paper has focused on the challenges to
learning in health markets, we are optimistic that
investment to address these challenges and acceler-
ate learning can ultimately bring about significantimprovements in the functioning of health markets,
especially for the poor.Endnotes
aNotable examples include the Center for Health
Market Innovation, HANSHEP, and the Private Sector
Working Group of the SHOPS project. Other initiatives
(such as HealthUnbound, the International Partnership for
Innovative Health Care Delivery, Harmonization for Health
In Africa and the UN Secretary General’s Innovation Work-
ing Group for Every Woman, Every Child) have interests
that overlap with health markets, even if it is not their core
focus.
bThere are some ongoing studies of this nature for ex-
ample BU faculty (with support from CHMI) are exam-
ining the impact on the market of the entry of the
MedPlus Retail Pharmacy chain in Andrha Pradesh and
what happens to price and quality in the non-chain
pharmacies as a result of the new competition. In
Bangladesh ICDDRB is working through the Future
Health Systems Project to examine market dynamics
around the introduction of a new m-health scheme.
cSee for example the Health and Wellness Reports of
Euromonitor.
dSECI refers to the acronym for the different stages in
the process of knowledge acquisition and formalization,
namely: Socialization (where tacit knowledge is shared);
Externalization (where tacit knowledge is converted into
explicit knowledge); Combination (where different forms
of formal knowledge come together) and Internalization
(where individuals reflect and absorb the new developed
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